Sudha Kodali, MBBS

Associate Professor of Clinical Medicine, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Publications

Pushing the limits of treatment for hepatocellular carcinoma
Jones-Pauley, M, Victor, DW & Kodali, S 2024, , Current opinion in organ transplantation, vol. 29, no. 1, pp. 3-9. https://doi.org/10.1097/MOT.0000000000001123

Transplant Oncology: An Emerging Discipline of Cancer Treatment
Abdelrahim, M, Esmail, A, Abudayyeh, A, Murakami, N, Victor, D, Kodali, S, Cheah, YL, Simon, CJ, Noureddin, M, Connor, A, Saharia, A, Moore, LW, Heyne, K, Kaseb, AO, Gaber, AO & Ghobrial, RM 2023, , Cancers, vol. 15, no. 22, 5337, pp. 5337. https://doi.org/10.3390/cancers15225337

Modern Outcomes After Liver Retransplantation: A Single-center Experience
Connor, AA, Saharia, A, Mobley, CM, Hobeika, MJ, Victor, DW, Kodali, S, Brombosz, EW, Graviss, EA, Nguyen, DT, Moore, LW, Gaber, AO & Ghobrial, RM 2023, , Transplantation, vol. 107, no. 7, pp. 1513-1523. https://doi.org/10.1097/TP.0000000000004500

Women’s health issues in solid organ transplantation: Breast and gynecologic cancers in the post-transplant population
Jones-Pauley, M, Kodali, S, Basra, T & Victor, DW 2023, , World Journal of Transplantation, vol. 13, no. 4, pp. 129-137. https://doi.org/10.5500/wjt.v13.i4.129

Factors affecting survival after liver retransplantation: a systematic review and meta-analysis
Brombosz, EW, Moore, LW, Mobley, CM, Kodali, S, Saharia, A, Hobeika, MJ, Connor, AA, Victor, III, DW, Cheah, YL, Simon, CJ, Gaber, AO & Ghobrial, RM 2023, , Frontiers in Transplantation, vol. 2, pp. 1181770. https://doi.org/10.3389/frtra.2023.1181770

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology
Abboud, K, Umoru, G, Esmail, A, Abudayyeh, A, Murakami, N, Al-Shamsi, HO, Javle, M, Saharia, A, Connor, AA, Kodali, S, Ghobrial, RM & Abdelrahim, M 2023, , Cancers, vol. 15, no. 5, 1433. https://doi.org/10.3390/cancers15051433

Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
Ahmed, Z, Lee, SS, Victor, DW & Kodali, S 2023, , Journal of Hepatocellular Carcinoma, vol. 10, pp. 1911-1922. https://doi.org/10.2147/JHC.S395080

960P Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
Abdelrahim, M, Esmail, A, He, AR, Franses, J, Bhan, I, Victor, III, DW, Kodali, S, Connor, AA, Saharia, A, Brdiges, C, Tin, T, Brewer, C, Jurdi, A, Liu, MC & Ghobrial, RM 2023, , Annals of Oncology, vol. 34, pp. S600. https://doi.org/10.1016/j.annonc.2023.09.2106

Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology: Cancers
Abboud, K, Umoru, G, Esmail, A, Abudayyeh, A, Murakami, N, Al-Shamsi, HO, Javle, M, Saharia, A, Connor, AA, Kodali, S, Ghobrial, RM & Abdelrahim, M 2023, .. https://doi.org/10.3390/cancers15051433

Trial in Progress: Neoadjuvant Combination Therapy of Lenvatinib Plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-eligible Patients with Large HCC: Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.
Abdelrahim, M, Esmail, A, Saharia, A, Kodali, S, Victor, D, Heyne, K & Ghobrial, RM 2023, , HPB, vol. 25, pp. S560. https://doi.org/10.1016/j.hpb.2023.07.755

Comparison of resection versus liver transplantation for intrahepatic cholangiocarcinoma: Past, present, and future directions
Kodali, S, Connor, AA, Thabet, S, Brombosz, EW & Ghobrial, RM 2023, , Hepatobiliary and Pancreatic Diseases International. https://doi.org/10.1016/j.hbpd.2023.07.007

Intrahepatic cholangiocarcinoma: The role of liver transplantation, adjunctive treatments, and prognostic biomarkers
Connor, AA, Kodali, S, Abdelrahim, M, Javle, MM, Brombosz, EW & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, 996710, pp. 996710. https://doi.org/10.3389/fonc.2022.996710

Liver transplantation and intrahepatic cholangiocarcinoma: Time to go forward again?
Kodali, S, Saharia, A & Ghobrial, RM 2022, , Current opinion in organ transplantation, vol. 27, no. 4, pp. 320-328. https://doi.org/10.1097/MOT.0000000000000983

Liver transplantation and intrahepatic cholangiocarcinoma: time to go forward again?
Kodali, S, Saharia, A & Ghobrial, RM 2022, , Current opinion in organ transplantation, vol. 27, no. 4, pp. 320-328. https://doi.org/10.1097/MOT.0000000000000983

Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
Abdelrahim, M, Esmail, A, Xu, J, Umoru, G, Al-Rawi, H, Saharia, A, Abudayyeh, A, Victor, D, McMillan, RR, Kodali, S & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, 908687, pp. 908687. https://doi.org/10.3389/fonc.2022.908687, https://doi.org/10.3389/fonc.2022.908687

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
Abdelrahim, M, Victor, D, Esmail, A, Kodali, S, Graviss, EA, Nguyen, DT, Moore, LW, Saharia, A, McMillan, RR, Fong, JN, Uosef, A, Elshawwaf, M, Heyne, K & Ghobrial, RM 2022, , Cancers, vol. 14, no. 3, 650. https://doi.org/10.3390/cancers14030650, https://doi.org/10.3390/cancers14030650

Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience
Abdelrahim, M, Victor, D, Esmail, A, Kodali, S, Graviss, EA, Nguyen, DT, Moore, LW, Saharia, A, McMillan, R, Fong, JN, Uosef, A, Elshawwaf, M, Heyne, K & Ghobrial, RM 2022, , Cancers, vol. 14, no. 3. https://doi.org/10.3390/cancers14030650

Long-Term Management of the Successful Adult Liver Transplant: A Patient-Friendly Summary of the 2012 AASLD and AST Practice Guideline
Shetty, A & Kodali, S 2022, , Clinical Liver Disease, vol. 19, no. 3, pp. 83-88. https://doi.org/10.1002/cld.1179

Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
Abdelrahim, M, Esmail, A, Xu, J, Umoru, G, Al-Rawi, H, Saharia, A, Abudayyeh, A, Victor, D, McMillan, R, Kodali, S & Ghobrial, RM 2022, , Frontiers in Oncology, vol. 12, pp. 908687. https://doi.org/10.3389/fonc.2022.908687

P-163 Tyrosine kinase inhibitors (TKIs) plus transarterial chemoembolization (TACE) compared to TACE alone as downstaging therapy in transplant recipients with hepatocellular carcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022
Esmail, A, Kodali, S, Graviss, E, Nguyen, D, Moore, L, Saharia, A, Uosef, A, Victor, D & Abdelrahim, M 2022, , Annals of Oncology, vol. 33, pp. S308. https://doi.org/10.1016/j.annonc.2022.04.253